Shengzheng Wang

First Affiliated Hospital of Zhengzhou University

Papers

4

Total Citations

25

H-Index

3

About

Shengzheng Wang is a pioneering urologic surgeon whose research focuses on advanced robotic and telesurgical approaches for complex genitourinary cancers, particularly bladder cancer and renal cell carcinoma with inferior vena cava (IVC) tumor thrombus. His most impactful work includes identifying preoperative predictors of early death in bladder cancer patients undergoing robot-assisted radical cystectomy (14 citations), providing critical risk stratification tools that can guide clinical decision-making and improve survival outcomes. Wang has made landmark contributions to the surgical management of level III IVC tumor thrombectomy, developing and refining a robot-assisted single-docking approach that addresses the technical challenges of this highly complex procedure (6 citations). His investigation into the renal functional impact of left renal vein ligation during en bloc resection of the IVC and right kidney (3 citations) offers vital insights for preserving renal function in aggressive oncologic surgery. Notably, Wang is at the forefront of surgical innovation through his multicenter study on 5G robotic telesurgery in urology (2 citations), demonstrating the feasibility and safety of remote surgical interventions—a transformative achievement that could expand access to specialized urologic care worldwide.

Research Focus

Key Achievements

3
H-Index
4
Papers
25
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Preoperative predictors of early death risk in bladder cancer patients treated with robot‐assisted radical cystectomy
14 citations · 2019
📈 Most Prolific Year: 2025 (2 Papers)
🤝 Key Collaborators: 18
🏛 Institutions: First Affiliated Hospital of Zhengzhou University

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago